Cenix BioScience
RNAi CRO Cenix Bioscience Shuts Down
The company was founded in 1999 to provide high-throughput target discovery and validation services for academic and industry partners.
Cenix, Metanomics Reach Research Agreement
NEW YORK (GenomeWeb) – Contract research organization Cenix BioScience this week announced a research framework agreement with metabolite services and biomarker firm Metanomics Health.
NEW YORK (GenomeWeb) – Cenix BioScience this week announced it has signed an agreement to provide target-validation services to BASF company Metanomics.
NEW YORK (GenomeWeb) – Cenix Biosciences this week announced that it has signed an agreement to provide RNAi-based high-content screening services to Germany's Bayer Pharma.
Cenix, Debiopharm Ink Biomarker ID Deal
NEW YORK (GenomeWeb News) – Cenix BioScience and Debiopharm Group today announced a research agreement to use Cenix's technology in support of Debiopharm's drug development efforts.
May 23, 2013
Oct 4, 2012
Sep 27, 2012
Mar 1, 2012
Dec 13, 2011
Nov 17, 2011
May 5, 2011
Mar 31, 2011
Cenix Joins EU siRNA Consortium
Premium
Jan 13, 2011
Jun 15, 2009
Cenix Expands AstraZeneca Agreement
Apr 30, 2009
Mar 19, 2009
Cenix Continues AstraZeneca Partnership
Feb 5, 2009